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Purpose. To document a case of myxoid liposarcoma in which PET scan was less sensitive than MRI in detecting spinal metastasis.
Materials and Methods. The case of a 65-year-old female with a history of myxoid liposarcoma (MLS) of the thigh resected 5 years
previously and now presenting with low back pain is presented. Her medical oncologist ordered an FDG-PET scan to evaluate
distant recurrence. Subsequently, an MRI of her spine was obtained by her surgeon. Results. The FDG-PET scan was obtained 1
week prior to the MRI, and it did not show increased glucose uptake in the spine. Her MRI did show increased signal intensity in
her lumbar spine. CT needle biopsy conﬁrmed the lesion to be metastatic MLS. Conclusion. FDG-PET scans are utilized to detect
distant recurrence of cancerous lesions. Myxoid liposarcoma has a unique propensity to metastasize to the spine. Previous reports
have documented the unreliability of bone scintigraphy to diagnose these metastases. Our report demonstrates that FDG-PET
may also lack the sensitivity needed to detect these lesions. We advocate total spine MRI when screening for metastases in this
population when they present with back pain.
Copyright © 2007 J. H. Schwab and J. H. Healey. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Liposarcoma is one of the most common soft tissue sarco-
masandmyxoidliposarcoma(MLS)isthesecondmostcom-
mon subtype. Soft tissue sarcomas tend to metastasize to the
lungs, however myxoid liposarcoma may metastasize to un-
usual extrapulmonary sites including bone [1–3]. Several re-
ports have documented cases of metastatic MLS to the spine.
It is unclear which imaging modality has the greatest abil-
ity to detect these lesions. Bone scintigraphy has been shown
to be unreliable [4–6]. FDG-PET scans are being utilized in
many centers to detect metastases, however their sensitivity
and speciﬁcity is not known. We present a case of metastatic
MLS to the spine which was not detected by FDG-PET but
had a positive MRI.
1. CASE REPORT
A 65-year-old female with a history of an AJCC stage III
popliteal myxoid liposarcoma developed mild low back pain
5 years after her initial surgery. The primary tumor had been
treated with wide resection followed by 6500 cGy to the
poplitealfossa.Shehadbeendisease-freeandwasseenbyher
medical oncologist for a routine check when she complained
of back pain. Whole body FDG-PET (Figure 1(a)) did not
show increased glucose uptake in the lumbar spine (black
arrow). Subsequent axial MRI (Figure 1(b)) showed a soft
tissue component to a mass in the lumbar spine (white ar-
row). Sagittal MRI (Figure 1(c)) of the lumbar spine demon-
strates a lesion in the second lumbar vertebrae on T1 and
T2 weighted images. A CT-guided biopsy conﬁrmed the di-
agnosis of metastatic myxoid liposarcoma. The patient was
treated with intensity modulated radiation therapy (IMRT).
Her back pain subsided but she developed further systemic
disease and died.
2. DISCUSSION
Screening for metastatic liposarcoma is controversial. Chest
CT misses a signiﬁcant number of metastases as MLS has
a propensity to metastasize to extrapulmonary sites such as
the one in our case report. Bone scintigraphy is not a reli-
ablediagnostic testformetastaticmyxoid liposarcoma[4–6].
This case demonstrates that FDG-PET scanning may lack
suﬃcient sensitivity in diagnosing MLS metastases. The low
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Figure 1: (a) The PET scan did not demonstrate increased glucose uptake in the lumbar spine. (b) and (c) Axial and sagittal MRI demon-
srated abnormal signal intensity in the second lumber vertebrae.
found in the myxoid/paucicelluar regions of these tumors.
MRI appears to be the most reliable method of diagnosing
spinal metastasis in myxoid liposarcoma.
The negative PET scan may reﬂect low metabolic activ-
ity within the myxoid/paucicelluar regions of these tumors.
It is possible that the absence of appreciable glucose uptake
reﬂectstheinability ofthePETscanstodetectthosecellsthat
are actively utilizing glucose within the myxoid stroma. The
radiolabeled glucose may not be able to reach the cells em-
bedded in the matrix. However, our case represents a high-
grade liposarcoma with at least a 5% round cell component.
OnewouldexpectthattheseareascouldbedetectedbyFDG-
PET. Further study is necessary to determine whether the ra-
tio of round cells relative to myxoid stroma is important.
Spine metastasis should be considered when one is eval-
uating a patient with a history of MLS presenting with back
pain. Bone scintigraphy and FDG-PET do not seem to be
sensitiveenoughtodetecttheselesions.WerecommendMRI
of the spine when one is confronted with a patient complain-
ing of back pain with a history of myxoid liposarcoma. While
MRI seems to be more sensitive than FDG-PET, neither is
speciﬁc, and biopsy should be considered for histologic con-
ﬁrmation.
REFERENCES
[1] C.R.Antonescu,S.J .T schern ya vsky ,R.Decuseara,etal.,“P r og-
nosticimpactofP53status,TLS-CHOP fusiontranscriptstruc-
ture, and histological grade in myxoid liposarcoma: a molecu-
lar and clinicopathologic study of 82 cases,” Clinical Cancer Re-
search, vol. 7, no. 12, pp. 3977–3987, 2001.
[2] S. H. Estourgie, G. P. Nielsen, and M. J. Ott, “Metastatic pat-
terns of extremity myxoid liposarcoma and their outcome,”
Journal of Surgical Oncology, vol. 80, no. 2, pp. 89–93, 2002.J. H. Schwab and J. H. Healey 3
[3] S. E. Kilpatrick, J. Doyon, P. F. M. Choong, F. H. Sim, and A. G.
Nascimento, “The clinicopathologic spectrum of myxoid and
round cell liposarcoma: a study of 95 cases,” Cancer, vol. 77,
no. 8, pp. 1450–1458, 1996.
[4] R. Kirollos, G. Koutsoubelis, S. Ross, and S. Al Sarraj, “An un-
usual case of spinal metastasis from a liposarcoma,” European
Journal of Surgical Oncology, vol. 22, no. 3, pp. 303–305, 1996.
[5] T. Ishii, T. Ueda, A. Myoui, N. Tamai, N. Hosono, and H.
Yoshikawa, “Unusual skeletal metastases from myxoid liposar-
coma only detectable by MR imaging,” European Radiology,
vol. 13, supplement 6, pp. L185–L191, 2003.
[ 6 ]J .S .K h u r a n a ,D .I .R o s e n t h a l ,A .E .R o s e n b e r g ,a n dH .J .
Mankin, “Skeletal metastases in liposarcoma detectable only
by magnetic resonance imaging,” Clinical Orthopaedics and Re-
lated Research, no. 243, pp. 204–207, 1989.